Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Protopic vs Steroids on Vaccination Response in Pediatric Atopic Dermatitis
NCT00801957Phase 2Completed
- Sponsor
- Astellas Pharma
- Start
- Mar 2003
- Primary completion
- Nov 2004
- Modality
- RNA-Targeting Small Molecules
- Countries
- 8
01
Overview
A Phase 2 trial of Envarsus XR in atopic dermatitis (AD), sponsored by Astellas Pharma. Started Mar 2003; status: completed.
02
Drugs
Envarsus XR
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT00801957.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00801957.